Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Single-institution experience of medical students' bacterial colonization during training.

Saliba G, El Kary N, Bakouny Z, Dagher L, Mallah Hamdan M, Abdallah W.

Am J Infect Control. 2019 Mar;47(3):268-270. doi: 10.1016/j.ajic.2018.08.025. Epub 2019 Jan 5.

PMID:
30616931
2.

Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.

Marrero JA, Kudo M, Venook AP, Ye SL, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JH, de Guevara LL, Papandreou C, Takayama T, Sanyal AJ, Yoon SK, Nakajima K, Lehr R, Heldner S, Lencioni R.

J Hepatol. 2016 Dec;65(6):1140-1147. doi: 10.1016/j.jhep.2016.07.020. Epub 2016 Jul 25.

PMID:
27469901
3.

Genetic diversity of hepatitis B virus and mutations associated to hepatocellular carcinoma in patients from Venezuela, with different stages of liver disease.

Puche ML, Kay-Valero S, Michelli P, Oropeza MD, Loureiro CL, Devesa M, Dagher L, Pujol FH.

Invest Clin. 2016 Mar;57(1):38-46.

PMID:
27382800
4.

Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.

Kudo M, Lencioni R, Marrero JA, Venook AP, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JF, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Yoon SK, Nakajima K, Lehr R, Heldner S, Ye SL.

Liver Int. 2016 Aug;36(8):1196-205. doi: 10.1111/liv.13096. Epub 2016 Apr 1.

PMID:
26901163
5.

TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.

Geschwind JF, Kudo M, Marrero JA, Venook AP, Chen XP, Bronowicki JP, Dagher L, Furuse J, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Ye SL, Yoon SK, Nakajima K, Lehr R, Heldner S, Lencioni R.

Radiology. 2016 May;279(2):630-40. doi: 10.1148/radiol.2015150667. Epub 2016 Jan 8.

PMID:
26744927
6.

Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.

Méndez-Sánchez N, Paraná R, Cheinquer H, Alves de Mattos A, Gadano A, Silva M, Pessôa MG, Gomes-Ferraz ML, Soza A, Mendes-Correa MC, Chávez-Tapia NC, Dagher L, Padilla M, Hernandez N, Sánchez-Avila JF, Contreras F, Moraes-Coelho HS, Parise ER, Bessone F, Uribe M; Latin American Association for the Study of the Liver.

Ann Hepatol. 2014 Aug;13 Suppl 2:s4-66. Review. No abstract available.

7.

Latin American Association for the Study of the Liver (LAASL) clinical practice guidelines: management of hepatocellular carcinoma.

Méndez-Sánchez N, Ridruejo E, Alves de Mattos A, Chávez-Tapia NC, Zapata R, Paraná R, Mastai R, Strauss E, Guevara-Casallas LG, Daruich J, Gadano A, Parise ER, Uribe M, Aguilar-Olivos NE, Dagher L, Ferraz-Neto BH, Valdés-Sánchez M, Sánchez-Avila JF.

Ann Hepatol. 2014 May;13 Suppl 1:S4-40. Review.

8.

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis.

Lencioni R, Kudo M, Ye SL, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JF, de Guevara LL, Papandreou C, Takayama T, Yoon SK, Nakajima K, Lehr R, Heldner S, Sanyal AJ.

Int J Clin Pract. 2014 May;68(5):609-17. doi: 10.1111/ijcp.12352. Epub 2013 Nov 28.

9.

[Postpartum hemorrhage by vaginal laseration: new case and improved management].

Gitz L, Picone O, Mas AE, Dagher L, Deffieux X.

J Gynecol Obstet Biol Reprod (Paris). 2014 May;43(5):401-6. doi: 10.1016/j.jgyn.2013.03.017. Epub 2013 May 22. French.

10.

First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study.

Lencioni R, Kudo M, Ye SL, Bronowicki JP, Chen XP, Dagher L, Furuse J, Geschwind JF, Ladrón de Guevara L, Papandreou C, Sanyal AJ, Takayama T, Yoon SK, Nakajima K, Cihon F, Heldner S, Marrero JA.

Int J Clin Pract. 2012 Jul;66(7):675-83. doi: 10.1111/j.1742-1241.2012.02940.x. Erratum in: Int J Clin Pract. 2012 Sep;66(9):912. de Guevara, L L [corrected to Ladrón de Guevara, L].

11.

Trends and projections of hepatitis C virus epidemiology in Latin America.

Kershenobich D, Razavi HA, Sánchez-Avila JF, Bessone F, Coelho HS, Dagher L, Gonçales FL, Quiroz JF, Rodriguez-Perez F, Rosado B, Wallace C, Negro F, Silva M.

Liver Int. 2011 Jul;31 Suppl 2:18-29. doi: 10.1111/j.1478-3231.2011.02538.x. Review.

PMID:
21651701
12.

Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?

Lencioni R, Chen XP, Dagher L, Venook AP.

Oncologist. 2010;15 Suppl 4:42-52. doi: 10.1634/theoncologist.2010-S4-42. Review.

13.

Genotype F prevails in Venezuelan urban patients with chronic hepatitis B.

Machado IV, del Pilar Fortes M, Vargas-Lovelle B, Trómpiz AC, López DA, León RV, Senior M, Dagher L, López CE, Pestana E, Bacalao R, Garassini ME.

Ann Hepatol. 2010 Apr-Jun;9(2):172-6.

14.

Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela.

Fortes Mdel P, Machado IV, Gil G, Fernández-Mestre M, Dagher L, León RV, Bianco NE, Tassinari P.

Liver Int. 2007 Dec;27(10):1409-16. Epub 2007 Oct 9.

PMID:
17927716
15.

Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation.

Raimondo ML, Dagher L, Papatheodoridis GV, Rolando N, Patch DW, Davidson BR, Rolles K, Burroughs AK.

Transplantation. 2003 Jan 27;75(2):186-90.

PMID:
12548120
16.

Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?

Burroughs AK, Groszmann R, Bosch J, Grace N, Garcia-Tsao G, Patch D, Garcia-Pagan JC, Dagher L.

Gut. 2002 Mar;50(3):425-7. Review.

17.

Acute variceal bleeding: general management.

Patch D, Dagher L.

World J Gastroenterol. 2001 Aug;7(4):466-75. Review. No abstract available.

18.

The hepatorenal syndrome.

Dagher L, Moore K.

Gut. 2001 Nov;49(5):729-37. Review. No abstract available.

19.

Acute jaundice.

Burroughs A, Dagher L.

Clin Med (Lond). 2001 Jul-Aug;1(4):285-9. Review. No abstract available.

20.

Variceal bleeding and portal hypertensive gastropathy.

Dagher L, Burroughs A.

Eur J Gastroenterol Hepatol. 2001 Jan;13(1):81-8. Review.

PMID:
11204818
21.

Management of oesophageal varices.

Dagher L, Patch D, Burroughs A.

Hosp Med. 2000 Oct;61(10):711-7. Review.

PMID:
11103283
22.

Drug treatment for bleeding oesophageal varices.

Dagher L, Patch D, Burroughs A.

Baillieres Best Pract Res Clin Gastroenterol. 2000 Jun;14(3):365-90. Review.

PMID:
10952803
23.

Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients.

Dagher L, Patch D, Marley R, Moore K, Burroughs A.

Aliment Pharmacol Ther. 2000 May;14(5):515-21. Review.

24.

Influence of positive crossmatch in the outcome of liver transplantation.

Dagher L, Chavez R, Taylor C, Smith ST, Alexander G, Jamieson N.

Transplant Proc. 1999 Sep;31(6):2363. No abstract available.

PMID:
10500618
25.

[Statistics on basocellular carcinoma in Londrina, Paraná, Brazil].

Minelli L, Pereira VL, Dagher L.

Bol Oficina Sanit Panam. 1982 Jul;93(1):10-7. Portuguese. No abstract available.

PMID:
6215042

Supplemental Content

Loading ...
Support Center